Story perspectives

Breakthroughs in Alzheimer's Research: New Targets and Trials Ahead

9/25/2025

Summary

Story summary

Despite over $30 billion in funding since 1984, Alzheimer's has no effective treatments.
Research shifted toward glial roles with telomere shortening, mitochondrial signaling, energy metabolism, and inflammation linked.
Purdue University finds excess microglial fat.
University of Utah studies blood samples to explore links between hypertension and Alzheimer's.
Illimis Therapeutics aims to remove amyloid beta without inflammation, with trials in 2027.

1 of 1

Story summary

Despite over $30 billion in funding since 1984, Alzheimer's has no effective treatments.
Research shifted toward glial roles with telomere shortening, mitochondrial signaling, energy metabolism, and inflammation linked.
Purdue University finds excess microglial fat.
University of Utah studies blood samples to explore links between hypertension and Alzheimer's.
Illimis Therapeutics aims to remove amyloid beta without inflammation, with trials in 2027.